Přihlásit se Zaregistrujte se zdarma

Poměr krácení společnosti Agile Therapeutics Inc

Jaká je hodnota metriky Poměr krácení společnosti Agile Therapeutics Inc?

Hodnota metriky Poměr krácení společnosti Agile Therapeutics Inc je 1.33

Jaká je definice metriky Poměr krácení?



Poměr krácení (Short ratio) je poměr akcií prodaných na krátko vydělený průměrným denním objemem.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Poměr krácení společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Agile Therapeutics Inc

Čemu se věnuje společnost Agile Therapeutics Inc?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Firmy s metrikou poměr krácení podobnou společnosti Agile Therapeutics Inc